임플란트 주위염 시장 규모, 점유율, 동향 분석 리포트 : 방법 유형별, 지역별, 부문 예측(2025-2030년)

Peri-implantitis Market Growth & Trends:

The global peri-implantitis market size is expected to reach USD 1.75 billion by 2030, expanding at a CAGR of 9.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Peri-implantitis is a site-specific destructive inflammatory disease affecting soft and hard tissues around osseointegrated implants, causing a decrease in bone volume and formation of peri-implant pockets. The success rate of dental implants was reported to be 92%-98% over a period of 10 years. Yet, factors like increasing patients with a history of periodontitis, the advent of technological advancement pertaining to efficient treatment of peri-implantitis, and a rise in the patient population prone to smoking and diabetes are fueling the market growth.

The prevalence of peri-implant complication is expected to be on the rise with the increased number of implants being placed around the globe. According to NCBI, in the U.S. from 1999 to 2017, per year 14.0% increase in implant prevalence was recorded. Annually there are about 2,60,000 implants placed in the U.K., which indicates the growing demand for dental implants. As implants are becoming a common treatment, associated disease prevalence including peri-implant mucositis and peri-implantitis shows a positive correlation. Moreover, according to the CDC, 47.2% of adults aged 30 years in the U.S suffered from some form of periodontal disease in 2019. The condition is more common in men than women as they are more prone to smoking and health conditions like diabetes. Advancements like laser debridement, guided bone regeneration (GBR), and diagnostic genetic biomarker technique are expected to boost peri-implantitis treatment market growth.

Peri-implantitis Market Report Highlights:

• The surgical segment dominated the market in 2024 due to the fact that surgical debridement procedures are efficient and are considered as the most effective technique to treat peri-implantitis
• Laser debridement non-surgical technique is anticipated to witness the highest growth over the forecast period as it has improved clinical outcomes are efficient due to selective calculus removal
• Europe dominated the market in 2024 owing to the rising technological advancements for peri-implantitis treatment
• In the Asia Pacific, the market is expected to witness the highest CAGR over the forecast period owing to the growing geriatric patient population, rising awareness about dental implants and associated disease, and rapid technological advancements.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Method Type
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Peri-implantitis Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Peri-implantitis Market: Method Type Business Analysis

• 4.1. Method Type Market Share, 2024 & 2030
• 4.2. Method Type Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Method Type, 2018 to 2030 (USD Billion)
• 4.4. Surgical
  • 4.4.1. Surgical Market, 2018 - 2030 (USD Billion)
  • 4.4.2. Bone Regeneration
    • 4.4.2.1. Bone Regeneration Market, 2018 - 2030 (USD Billion)
  • 4.4.3. Open Flap Debridement
    • 4.4.3.1. Open Flap Debridement Market, 2018 - 2030 (USD Billion)
  • 4.4.4. Implantoplasty
    • 4.4.4.1. Implantoplasty Market, 2018 - 2030 (USD Billion)
• 4.5. Non-surgical
  • 4.5.1. Non-surgical Market, 2018 - 2030 (USD Billion)
  • 4.5.2. Mechanical Debridement
    • 4.5.2.1. Mechanical Debridement Market, 2018 - 2030 (USD Billion)
  • 4.5.3. Laser Debridement
    • 4.5.3.1. Laser Debridement Market, 2018 - 2030 (USD Billion)
  • 4.5.4. Antibiotics
    • 4.5.4.1. Antibiotics Market, 2018 - 2030 (USD Billion)
  • 4.5.5. Others
    • 4.5.5.1. Others Market, 2018 - 2030 (USD Billion)

Chapter 5. Peri-implantitis Market: Regional Estimates & Trend Analysis

• 5.1. Regional Market Share Analysis, 2024 & 2030
• 5.2. Regional Market Dashboard
• 5.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 5.4. North America
  • 5.4.1. North America Peri-implantitis Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
  • 5.4.2. U.S.
    • 5.4.2.1. Key Country Dynamics
    • 5.4.2.2. Regulatory Framework
    • 5.4.2.3. Competitive Insights
    • 5.4.2.4. U.S. Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.4.3. Canada
    • 5.4.3.1. Key Country Dynamics
    • 5.4.3.2. Regulatory Framework
    • 5.4.3.3. Competitive Insights
    • 5.4.3.4. Canada Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.4.4. Mexico
    • 5.4.4.1. Key Country Dynamics
    • 5.4.4.2. Regulatory Framework
    • 5.4.4.3. Competitive Insights
    • 5.4.4.4. Mexico Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.5. Europe
  • 5.5.1. Europe Peri-implantitis Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
  • 5.5.2. UK
    • 5.5.2.1. Key Country Dynamics
    • 5.5.2.2. Regulatory Framework
    • 5.5.2.3. Competitive Insights
    • 5.5.2.4. UK Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.5.3. Germany
    • 5.5.3.1. Key Country Dynamics
    • 5.5.3.2. Regulatory Framework
    • 5.5.3.3. Competitive Insights
    • 5.5.3.4. Germany Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.5.4. France
    • 5.5.4.1. Key Country Dynamics
    • 5.5.4.2. Regulatory Framework
    • 5.5.4.3. Competitive Insights
    • 5.5.4.4. France Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.5.5. Italy
    • 5.5.5.1. Key Country Dynamics
    • 5.5.5.2. Regulatory Framework
    • 5.5.5.3. Competitive Insights
    • 5.5.5.4. Italy Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.5.6. Spain
    • 5.5.6.1. Key Country Dynamics
    • 5.5.6.2. Regulatory Framework
    • 5.5.6.3. Competitive Insights
    • 5.5.6.4. Spain Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.5.7. Norway
    • 5.5.7.1. Key Country Dynamics
    • 5.5.7.2. Regulatory Framework
    • 5.5.7.3. Competitive Insights
    • 5.5.7.4. Norway Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.5.8. Denmark
    • 5.5.8.1. Key Country Dynamics
    • 5.5.8.2. Regulatory Framework
    • 5.5.8.3. Competitive Insights
    • 5.5.8.4. Denmark Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.5.9. Sweden
    • 5.5.9.1. Key Country Dynamics
    • 5.5.9.2. Regulatory Framework
    • 5.5.9.3. Competitive Insights
    • 5.5.9.4. Sweden Peri-implantitis Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
• 5.6. Asia Pacific
  • 5.6.1. Asia Pacific Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6.2. Japan
    • 5.6.2.1. Key Country Dynamics
    • 5.6.2.2. Regulatory Framework
    • 5.6.2.3. Competitive Insights
    • 5.6.2.4. Japan Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6.3. China
    • 5.6.3.1. Key Country Dynamics
    • 5.6.3.2. Regulatory Framework
    • 5.6.3.3. Competitive Insights
    • 5.6.3.4. China Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6.4. India
    • 5.6.4.1. Key Country Dynamics
    • 5.6.4.2. Regulatory Framework
    • 5.6.4.3. Competitive Insights
    • 5.6.4.4. India Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6.5. South Korea
    • 5.6.5.1. Key Country Dynamics
    • 5.6.5.2. Regulatory Framework
    • 5.6.5.3. Competitive Insights
    • 5.6.5.4. South Korea Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6.6. Australia
    • 5.6.6.1. Key Country Dynamics
    • 5.6.6.2. Regulatory Framework
    • 5.6.6.3. Competitive Insights
    • 5.6.6.4. Australia Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6.7. Thailand
    • 5.6.7.1. Key Country Dynamics
    • 5.6.7.2. Regulatory Framework
    • 5.6.7.3. Competitive Insights
    • 5.6.7.4. Thailand Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.7. Latin America
  • 5.7.1. Latin America Peri-implantitis Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
  • 5.7.2. Brazil
    • 5.7.2.1. Key Country Dynamics
    • 5.7.2.2. Regulatory Framework
    • 5.7.2.3. Competitive Insights
    • 5.7.2.4. Brazil Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.7.3. Argentina
    • 5.7.3.1. Key Country Dynamics
    • 5.7.3.2. Regulatory Framework
    • 5.7.3.3. Competitive Insights
    • 5.7.3.4. Argentina Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.8. MEA
  • 5.8.1. MEA Peri-implantitis Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
  • 5.8.2. South Africa
    • 5.8.2.1. Key Country Dynamics
    • 5.8.2.2. Regulatory Framework
    • 5.8.2.3. Competitive Insights
    • 5.8.2.4. South Africa Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.8.3. Saudi Arabia
    • 5.8.3.1. Key Country Dynamics
    • 5.8.3.2. Regulatory Framework
    • 5.8.3.3. Competitive Insights
    • 5.8.3.4. Saudi Arabia Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.8.4. UAE
    • 5.8.4.1. Key Country Dynamics
    • 5.8.4.2. Regulatory Framework
    • 5.8.4.3. Competitive Insights
    • 5.8.4.4. UAE Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.8.5. Kuwait
    • 5.8.5.1. Key Country Dynamics
    • 5.8.5.2. Regulatory Framework
    • 5.8.5.3. Competitive Insights
    • 5.8.5.4. Kuwait Peri-implantitis Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Competitive Landscape

• 6.1. Participant Overview
• 6.2. Company Market Position Analysis
• 6.3. Company Categorization
• 6.4. Strategy Mapping
• 6.5. Company Profiles/Listing
  • 6.5.1. Pfizer Inc.
    • 6.5.1.1. Overview
    • 6.5.1.2. Financial Performance
    • 6.5.1.3. Method Type Benchmarking
    • 6.5.1.4. Strategic Initiatives
  • 6.5.2. Cadila Pharmaceuticals
    • 6.5.2.1. Overview
    • 6.5.2.2. Financial Performance
    • 6.5.2.3. Method Type Benchmarking
    • 6.5.2.4. Strategic Initiatives
  • 6.5.3. GaronitPharma
    • 6.5.3.1. Overview
    • 6.5.3.2. Financial Performance
    • 6.5.3.3. Method Type Benchmarking
    • 6.5.3.4. Strategic Initiatives
  • 6.5.4. Basic Pharma Life Science Pvt Ltd.
    • 6.5.4.1. Overview
    • 6.5.4.2. Financial Performance
    • 6.5.4.3. Method Type Benchmarking
    • 6.5.4.4. Strategic Initiatives
  • 6.5.5. Prachi Pharmaceuticals Private Limited.
    • 6.5.5.1. Overview
    • 6.5.5.2. Financial Performance
    • 6.5.5.3. Method Type Benchmarking
    • 6.5.5.4. Strategic Initiatives
  • 6.5.6. Geistlich Pharma India Pvt. Ltd.
    • 6.5.6.1. Overview
    • 6.5.6.2. Financial Performance
    • 6.5.6.3. Method Type Benchmarking
    • 6.5.6.4. Strategic Initiatives
  • 6.5.7. Healthy Life Pharma Private Limited.
    • 6.5.7.1. Overview
    • 6.5.7.2. Financial Performance
    • 6.5.7.3. Method Type Benchmarking
    • 6.5.7.4. Strategic Initiatives
  • 6.5.8. Zimmer Biomet.
    • 6.5.8.1. Overview
    • 6.5.8.2. Financial Performance
    • 6.5.8.3. Method Type Benchmarking
    • 6.5.8.4. Strategic Initiatives
  • 6.5.9. Institut Straumann AG
    • 6.5.9.1. Overview
    • 6.5.9.2. Financial Performance
    • 6.5.9.3. Method Type Benchmarking
    • 6.5.9.4. Strategic Initiatives
  • 6.5.10. Dentsply Sirona
    • 6.5.10.1. Overview
    • 6.5.10.2. Financial Performance
    • 6.5.10.3. Method Type Benchmarking
    • 6.5.10.4. Strategic Initiatives